Hospital Sant Joan de Deu

Esplugues de Llobregat, Catalonia 08950

0 studies enrolling now · 9 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Advanced Non CNS Tumors, Atopic Dermatitis, B Cell Precursor Acute Lymphoblastic Leukemia, Osteogenesis Imperfecta, Osteogenesis Imperfecta (OI), Psoriasis, Vasculitis

Studies at this site

• Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. — Running, not enrolling
• A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL — Running, not enrolling
• Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta — Running, not enrolling
• A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
• A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis — Completed
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia — Completed
• Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta — Completed
• Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors — Completed
• Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis Imperfecta — Stopped early